Funding academic oncology clinical trials.

被引：0
|
作者：
Seow, H.
Levine, M. N.
Bainbridge, D.
Kowaleski, B.
Arnold, A. M.
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Juravinski Canc Ctr, Hamilton, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e16507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16507
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Ancient clinical trials.
    Lewis, EJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01): : 83 - 84
  • [22] Glycitein for clinical trials.
    Verbruggen, MA
    Olieman, K
    [J]. JOURNAL OF NUTRITION, 2002, 132 (03): : 601S - 601S
  • [23] Trends in the content and format of main and optional consent forms in oncology clinical trials.
    Rummell, Sonja
    Chen, Leo
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [24] Institutional review of pediatric oncology patients participating in early phase clinical trials.
    Rami, Avina
    Bona, Kira
    Shusterman, Suzanne
    Wright, Karen D.
    Place, Andrew E.
    Umaretiya, Puja J.
    Bhushan, Ketki
    DuBois, Steven G.
    Campbell, Kevin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials.
    Rami, Avina
    DuBois, Steven G.
    Campbell, Kevin M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials.
    Bhandari, Sudip
    Mann, Jeremy
    Chawla, Jitesh
    Jain, Prerna
    Knight, Margot
    Lagor, Charles
    Mueller, Judith
    Raska, Paola
    Southwick, Steve
    Whyte, Warren
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18701 - E18701
  • [27] Violations of the proportional hazards assumption in randomized phase III oncology clinical trials.
    Rahman, Rifaquat
    Fell, Geoffrey
    Trippa, Lorenzo
    Alexander, Brian Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] ELICITING THE CHILD'S VOICE IN ADVERSE EVENT REPORTING IN ONCOLOGY CLINICAL TRIALS.
    Hinds, Pamela
    Reeve, Bryce
    Jaobs, Shana
    Baker, Justin
    Mack, Jenny
    Withycom, Janice
    [J]. ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [29] Trends in the content and format of main and optional consent forms in oncology clinical trials.
    Rummell, Sonja
    Chen, Leo
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials.
    Niranjan, Soumya J.
    Martin, Michelle Y.
    Fouad, Mona N.
    Vickers, Selwyn M.
    Wenzel, Jennifer
    Cook, Elise D.
    Konety, Badrinath R.
    Durant, Raegan W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
12345